Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Nanoparticle reduces targeted cancer drug's toxicity
The polymeric nanoparticle Accurin encapsulates the clinical candidate AZD2811, an Aurora B kinase inhibitor.
Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%
HYDERABAD, India & PRINCETON, N.
Mylan to buy Swedish drugmaker Meda in $7.2 billion deal
Generic drugmaker Mylan NV (MYL.
Medicare may experiment with caps to cancer-drug reimbursements
Look out, cancer drugmakers--the U.
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
Feb 9 (Reuters) - CTI BioPharma Corp said the U.
Pfizer Announces Leadership Team Upon Close of Allergan Deal
As previously announced, Brent Saunders will become president/CEO of the combined company with responsibility for Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy fun...
BioCryst Downgraded By JPMorgan, Analysts Await 'More Data'
Jim Swanson, Benzinga Staff Writer, February 09, 2016.
Astellas Names James Robinson President, Americas Operations
NORTHBROOK, Ill.
NICE says no to Praluent
Britain’s National Institute for Health and Care Excellence (NICE) has published draft guidance against prescribing the Sanofi (Euronext.
NIH researchers identify striking genomic signature shared by five types of cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Cognitive Behavioral Therapy: CBT May Change Brain Volume
New findings published in the journal Translational Psychiatry show that cognitive behavioral therapy (CBT) may help in changing brain volume.
Boehringer Ingelheim launches Spiriva Respimat in US market for maintenance treatment of asthma in adults & adolescents
Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, announced that Spiriva Respimat is now available for the treatment of asthma by prescription in US pharmacies.
49
50
51
52
53
54
55
56
57
